Literature DB >> 20531431

Parkinson disease: Parkinson disease-moving beyond association.

Owen A Ross, Matthew J Farrer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531431     DOI: 10.1038/nrneurol.2010.69

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

Review 1.  Genetics of Parkinson disease: paradigm shifts and future prospects.

Authors:  Matthew James Farrer
Journal:  Nat Rev Genet       Date:  2006-04       Impact factor: 53.242

2.  Common genetic variation and human traits.

Authors:  David B Goldstein
Journal:  N Engl J Med       Date:  2009-04-15       Impact factor: 91.245

3.  An agenda for personalized medicine.

Authors:  Pauline C Ng; Sarah S Murray; Samuel Levy; J Craig Venter
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

4.  Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population.

Authors:  Manabu Funayama; Yuanzhe Li; Hiroyuki Tomiyama; Hiroyo Yoshino; Yoko Imamichi; Mitsutoshi Yamamoto; Miho Murata; Tatsushi Toda; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Neuroreport       Date:  2007-02-12       Impact factor: 1.837

5.  Rare variants create synthetic genome-wide associations.

Authors:  Samuel P Dickson; Kai Wang; Ian Krantz; Hakon Hakonarson; David B Goldstein
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

Review 6.  Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.

Authors:  A C Ludolph; J Kassubek; B G Landwehrmeyer; E Mandelkow; E-M Mandelkow; D J Burn; D Caparros-Lefebvre; K A Frey; J G de Yebenes; T Gasser; P Heutink; G Höglinger; Z Jamrozik; K A Jellinger; A Kazantsev; H Kretzschmar; A E Lang; I Litvan; J J Lucas; P L McGeer; S Melquist; W Oertel; M Otto; D Paviour; T Reum; A Saint-Raymond; J C Steele; M Tolnay; H Tumani; J C van Swieten; M T Vanier; J-P Vonsattel; S Wagner; Z K Wszolek
Journal:  Eur J Neurol       Date:  2009-03       Impact factor: 6.089

7.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.

Authors:  Wataru Satake; Yuko Nakabayashi; Ikuko Mizuta; Yushi Hirota; Chiyomi Ito; Michiaki Kubo; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Masahiko Watanabe; Atsushi Takeda; Hiroyuki Tomiyama; Kenji Nakashima; Kazuko Hasegawa; Fumiya Obata; Takeo Yoshikawa; Hideshi Kawakami; Saburo Sakoda; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Yusuke Nakamura; Tatsushi Toda
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

8.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

  8 in total
  4 in total

1.  Human leukocyte antigen variation and Parkinson's disease.

Authors:  Andreas Puschmann; Christophe Verbeeck; Michael G Heckman; Alexandra I Soto-Ortolaza; Timothy Lynch; Barbara Jasinska-Myga; Grzegorz Opala; Anna Krygowska-Wajs; Maria Barcikowska; Ryan J Uitti; Zbigniew K Wszolek; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2011-04-11       Impact factor: 4.891

2.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

3.  A prognostic view on the application of individualized genomics in Parkinson's disease.

Authors:  Owen A Ross
Journal:  Curr Genet Med Rep       Date:  2013-01-12

4.  Association studies of sporadic Parkinson's disease in the genomic era.

Authors:  Catherine Labbé; Owen A Ross
Journal:  Curr Genomics       Date:  2014-02       Impact factor: 2.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.